Tech Company Financing Transactions
Reprogram Biosciences Funding Round
On 5/27/2026, Reprogram Biosciences raised $6 million in funding from 1517 Fund, Narya Capital and Unshackled Ventures.
Transaction Overview
Company Name
Announced On
5/27/2026
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds will support continued development of the company's lead program, expansion of its AI discovery engine, and CMC activities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1030 Brittan Ave
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Undisclosed
Website
Email Address
Overview
At Reprogram Biosciences, we are pioneering a groundbreaking immunotherapy approach that leverages gene reprogramming to transform cancer cells into immune-like cell types. Our vision is to empower the body's own defenses to fight cancer effectively and affordably.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rustam Esanov
Chief Operating Officer
Eziz Kuliyev
Browse more venture capital transactions:
Prev: 5/27/2026: viaim venture capital transaction
Next: 5/27/2026: Olyzon venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs